Osmoregulation and desmopressin pharmacokinetics in enuretic children

被引:26
作者
Nevéus, T
Läckgren, G
Tuvemo, T
Stenberg, A
机构
[1] Uppsala Univ, Childrens Hosp, Unit Pediat Internal Med, S-75185 Uppsala, Sweden
[2] Uppsala Univ, Childrens Hosp, Unit Pediat Urol, S-75185 Uppsala, Sweden
关键词
enuresis; desmopressin; osmoregulation;
D O I
10.1542/peds.103.1.65
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective. The aim was to compare responders and nonresponders to antienuretic treatment with desmopressin with respect to pharmacokinetics and renal effects of the drug. Methods. Twelve children, aged 7.6 to 16.2 years, with nocturnal enuresis were examined. Six patients were nonresponders and 6 were responders to desmopressin treatment. The children were given 2 mg of desmopressin intravenously and plasma concentrations of the drug were monitored overnight. Urine parameters were followed for 24 hours after desmopressin administration. Ten patients also underwent a thirst provocation test. Results. Desmopressin pharmacokinetics did not differ between the groups. Neither nocturnal urine production nor morning urine osmolality after desmopressin injection differed between responders and nonresponders, whereas the responders produced significantly larger amounts of significantly less concentrated urine during the day after the injection compared with the nonresponders (urine production, 2.02 +/- 0.84 and 0.77 +/- 0.20 mL/kg/h; urine osmolality, 558 +/- 271 and 883 +/- 134 mOsm/kg). Nonresponders voided with smaller bladder volumes (2.43 +/- 0.68 mL/kg body weight) than responders (4.70 +/- 1.21 mL/kg). The responders produced significantly less concentrated urine than the nonresponders during the thirst provocation test (607 +/- 185 and 922 +/- 217 mOsm/kg, respectively). Conclusion. Intravenous desmopressin pharmacokinetics and desmopressin renal effects did not differ between responders and nonresponders to desmopressin treatment. Nonresponders had a smaller spontaneous bladder capacity and responders produced less concentrated urine.
引用
收藏
页码:65 / 70
页数:6
相关论文
共 29 条
[1]  
ANDERSSON K-E, 1988, Drugs of Today, V24, P509
[2]  
BIRKASOVA M, 1978, PEDIATRICS, V62, P970
[3]  
BROEDERS A, 1995, METHOD VALIDATION RA
[4]   ABSOLUTE BIOAVAILABILITY OF AN AQUEOUS-SOLUTION OF 1-DEAMINO-8-D-ARGININE VASOPRESSIN FROM DIFFERENT REGIONS OF THE GASTROINTESTINAL-TRACT IN MAN [J].
DAGAYABENSOUR, L ;
FJELLESTADPAULSEN, A ;
HOGLUND, P ;
NGO, Y ;
PAULSEN, O ;
RAMBAUD, JC .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (05) :473-476
[5]   VASOPRESSIN ANALOG DDAVP IN DIABETES-INSIPIDUS - CLINICAL AND LABORATORY STUDIES [J].
EDWARDS, CRW ;
KITAU, MJ ;
CHARD, T ;
BESSER, GM .
BRITISH MEDICAL JOURNAL, 1973, 3 (5876) :375-378
[6]  
Eller DA, 1997, SCAND J UROL NEPHROL, V31, P41
[7]   DESMOPRESSIN FOR BED-WETTING - LENGTH OF TREATMENT, VASOPRESSIN SECRETION, AND RESPONSE [J].
EVANS, JHC ;
MEADOW, SR .
ARCHIVES OF DISEASE IN CHILDHOOD, 1992, 67 (02) :184-188
[8]   PHARMACOKINETICS OF 1-DEAMINO-8-D-ARGININE VASOPRESSIN AFTER VARIOUS ROUTES OF ADMINISTRATION IN HEALTHY-VOLUNTEERS [J].
FJELLESTADPAULSEN, A ;
HOGLUND, P ;
LUNDIN, S ;
PAULSEN, O .
CLINICAL ENDOCRINOLOGY, 1993, 38 (02) :177-182
[9]  
HAMMER M, 1985, J PHARMACOL EXP THER, V234, P754
[10]  
HJALMAS K, 1993, CLIN PEDIATR, P19